一个可解释的几何图形神经网络,用于提高药物向相互作用预测的概括性
An Xiong1, Zhenjie Luo1, Yan Xia1
1School of Computer Science and Technology, Hainan University, Haikou, 570228, China.
BMC biology
|November 27, 2025
概括
GPS-DTI通过使用新型深度学习框架准确预测药物向相互作用 (DTI) 来增强药物发现. 这种方法提高了新药和标的概括性,推动了计算药物开发.
科学领域:
- 计算生物学是一种计算生物学.
- 药物发现 药物发现
- 机器学习是机器学习.
背景情况:
- 准确预测药物向相互作用 (DTI) 对药物发现至关重要.
- 现有的计算方法往往难以将其推广到新的药物或目标.
研究的目的:
- 开发一个强大的深度学习框架,GPS-DTI,用于更好地预测药物向相互作用.
- 提高DTI预测模型的概括能力.
主要方法:
- GPS-DTI使用带有边缘特征 (GINE) 的图形同态网络和多头注意力机制 (MHAM) 进行药物分子建模.
- 蛋白质表示是使用进化量级模型 (ESM-2) 生成的,并通过卷积神经网络 (CNN) 进行细化.
- 一个交叉注意模块整合了药物和蛋白质特征,用于相互作用预测和解释性.
主要成果:
- 在域内和跨域的DTI预测任务中,GPS-DTI在现有方法中表现出优越的性能.
- 该模型在药物向亲和力 (DTA) 预测方面取得了最先进的结果.
- 在独立的COVID-19数据集上,GPS-DTI显示了强大的概括.
结论:
- GPS-DTI为预测药物向相互作用提供了强大的概括能力.
- 该框架通过交叉注意力图提供了对分子相互作用的可解释的见解.
- GPS-DTI对现实世界药物发现应用具有重大潜力.
相关概念视频
Quantitative Aspects of Drug-Receptor Interaction
1.7K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.7K
Protein-protein Interfaces
14.4K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
14.4K
Drug-Receptor Interactions
7.2K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
7.2K
Agonism and Antagonism: Quantification
952
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
952
Protein Networks
4.5K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.5K
Structure-Activity Relationships and Drug Design
1.7K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.7K


